Suppr超能文献

早期移植物功能不良会影响活体供肾移植的长期预后。

Poor early graft function impairs long-term outcome in living donor kidney transplantation.

机构信息

Department of Surgery, Division of Vascular and Transplant Surgery, Radboud University Nijmegen Medical Center, Geert Grooteplein-Zuid 10, 6525 GA, Nijmegen, The Netherlands.

出版信息

World J Urol. 2013 Aug;31(4):901-6. doi: 10.1007/s00345-012-0835-z. Epub 2012 Feb 14.

Abstract

BACKGROUND

Poor early graft function (EGF) after living donor kidney transplantation (LDKT) has been found to decrease rejection-free graft survival rates. However, its influence on long-term graft survival remains inconclusive.

METHODS

Data were collected on 472 adult LDKTs performed between July 1996 and February 2010. Poor EGF was defined as the occurrence of delayed or slow graft function. Slow function was defined as serum creatinine above 3.0 mg/dL at postoperative day 5 without dialysis.

RESULTS

The incidence of slow and delayed graft function was 9.3 and 4.4%, respectively. Recipient overweight, pretransplant dialysis and warm ischemia were identified as risk factors for the occurrence of poor EGF. The rejection-free survival was worse for poor EGF as compared to immediate graft function with an adjusted hazard ratio (HR) of 6.189 (95% CI 4.075-9.399; p < 0.001). Long-term graft survival was impaired in the poor EGF group with an adjusted HR of 4.206 (95% CI 1.839-9.621; p = 0.001).

CONCLUSIONS

Poor EGF occurs in 13.7% of living donor kidney allograft recipients. Both, rejection-free and long-term graft survivals are significantly lower in patients with poor EGF as compared to patients with immediate graft function. These results underline the clinical relevance of poor EGF as phenomenon after LDKT.

摘要

背景

活体供肾移植(LDKT)后早期移植物功能不良(EGF)已被发现会降低无排斥反应的移植物存活率。然而,其对长期移植物存活的影响仍不确定。

方法

收集了 1996 年 7 月至 2010 年 2 月期间进行的 472 例成人 LDKT 的数据。EGF 不良定义为发生延迟或缓慢的移植物功能。功能缓慢定义为术后第 5 天无透析时血清肌酐超过 3.0mg/dL。

结果

缓慢和延迟移植物功能的发生率分别为 9.3%和 4.4%。受体超重、移植前透析和热缺血被确定为 EGF 不良发生的危险因素。与即时移植物功能相比,EGF 不良的无排斥反应存活率更差,调整后的危险比(HR)为 6.189(95%可信区间 4.075-9.399;p<0.001)。EGF 不良组的长期移植物存活率受损,调整后的 HR 为 4.206(95%可信区间 1.839-9.621;p=0.001)。

结论

在活体供肾移植受者中,13.7%的患者发生 EGF 不良。与即时移植物功能相比,EGF 不良患者的无排斥反应和长期移植物存活率明显较低。这些结果强调了 LDKT 后 EGF 不良作为一种现象的临床相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/934c/3732771/47703e82aa78/345_2012_835_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验